BEGIN:VCALENDAR PRODID:-AUCD VERSION:1.0 BEGIN:VEVENT DCREATED:20240328T123531 LAST-MODIFIED:20240328T123531 DTSTART:20130430T160000Z DTEND:20130430T170000Z SUMMARY;ENCODING=QUOTED-PRINTABLE:The Neurobiology of ADHD and Related Disorders LOCATION;ENCODING=QUOTED-PRINTABLE:Webinar DESCRIPTION;ENCODING=QUOTED-PRINTABLE:=0D=0A=0D=0A=0D=0A=0D=0AThis webinar is Part II of The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician. It is being jointly sponsored with the Yale School of Medicine, Section of Developmental-Behavioral Pediatrics. For more information about the webinar series, click here.=0D=0A=0D=0A=0D=0A=0D=0ACME/CEUs will be availabe. Click here to learn more.=0D=0A=0D=0ASpeaker: Amy F.T. Arnsten, PhD =0D=0ARead bio here.=0D=0A=0D=0ASession Description: =0D=0AThis session will describe the prefrontal cortex's role in attention, behavior and emotion and how abnormal development in this area of the brain contributes to ADHD, ODD and bipolar disorder. Dr. Arnsten will also underscore the role of stress in causing prefrontal cortical dysfunction and emerging treatments.=0D=0A=0D=0AGoals and Objectives: =0D=0A1) The role of the prefrontal cortex in the top-down regulation of attention, behavior and emotion. =0D=0A2) How abnormal development and dysfunction of the prefrontal cortex contributes to childhood disorders such as Attention Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder and bipolar disorder. =0D=0A3) How prefrontal cortical circuits are modulated by the arousal systems, and how stress exposure or lead poisoning can cause prefrontal cortical dysfunction that mimics ADHD. =0D=0A4) New data on how medications used to treat ADHD can strengthen prefrontal cortical regulation through catecholamine actions on prefrontal network connections.=0D=0A=0D=0A=0D=0A=0D=0A =0D=0A PRIORITY:3 URL:http://www.aucd.org/template/event.cfm?event_id=3857&id=965 END:VEVENT END:VCALENDAR